Dr. Nair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3535 W 13 Mile Rd
Ste 344
Royal Oak, MI 48073Phone+1 248-551-0497Fax+1 248-551-4556
Education & Training
NYU Grossman Long Island School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 2007 - 2010
University of Kerala Medical CollegeClass of 2003
Certifications & Licensure
MI State Medical License 2007 - 2025
NY State Medical License 2013 - 2016
PA State Medical License 2013 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19.Huong N Q Tran, Malcolm Risk, Girish B Nair, Lili Zhao
NPJ Vaccines. 2024-09-13 - 5 citationsEfficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.Suzana Margareth Lobo, Gaétan Plantefève, Girish Nair, Adilson Joaquim Cavalcante, Nara Franzin de Moraes
Eclinicalmedicine. 2024-02-01 - 3 citationsStatic Respiratory System Compliance as a Predictor of Extubation Failure in Patients with Acute Respiratory Failure.Lauren A Abplanalp, Filip Ionescu, Enrique Calvo-Ayala, Limin Yu, Girish B Nair
Lung. 2023-06-01
Press Mentions
Screening and Diagnosis of Pulmonary Hypertension Associated with Chronic Lung Disease (PH-CLD): A Consensus Statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary HypertensionDecember 10th, 2024- Development and Validation of the Hospital Medicine Safety Sepsis Initiative Mortality ModelNovember 22nd, 2024
- COVA Trial: Success for Sarconeos in Hospitalized COVID-19 PatientsJune 2nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
